Radiosurgery Society Case-Based Guide to Stereotactic Body Radiation Therapy for Challenging Cases of Spinal Metastases.

Autor:	Aziz K; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Koffler D; Department of Radiation Oncology, Mayo Clinic, Jacksonville, FL 32224, USA., Vassantachart A; Department of Radiation Oncology, Keck School of Medicine of USC, Los Angeles, CA 90033, USA., Rattani A; Department of Radiation Oncology, Tufts Medical Center, Boston, Massachusetts 02111, USA., Ankrah NK; Department of Radiation Oncology, University of Alabama at Birmingham, Birmingham, Alabama, USA., Gogineni E; Department of Radiation Oncology, Arthur G. James Cancer Hospital/The Ohio State University, Columbus, OH, USA., Andraos TY; Department of Radiation Oncology, Arthur G. James Cancer Hospital/The Ohio State University, Columbus, OH, USA., Sahgal A; Department of Radiation Oncology, Sunnybrook Health Science Centre, University of Toronto, Toronto, Ontario, Canada., Vellayappan B; Department of Radiation Oncology, National University Cancer Institute Singapore, National University Hospital, Singapore., Dunne EM; Department of Radiation Oncology, British Columbia Cancer Agency - Vancouver Centre, Vancouver, British Columbia, Canada., Siva S; Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia., Moraes FY; Department of Oncology - Division of Radiation Oncology, Kingston Health Sciences Centre and Queen's University, Kingston, Canada., Guckenberger M; Department of Radiation Oncology, University Hospital Zurich, University of Zurich, Zurich, Switzerland., Lubelski D; Department of Neurological Surgery, The Johns Hopkins University, Baltimore, MD 21287, USA., Chao S; Department of Radiation Oncology, Taussig Cancer Center, Cleveland Clinic, Cleveland, Ohio., Combs S; Department of Radiation Oncology, School of Medicine, Klinikum rechts der Isar, Technical University Munich (TUM), Munich, Germany; Institute of Radiation Medicine (IRM), Department of Radiation Sciences, Helmholtz Zentrum Munich, Neuherberg, Germany; German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany., Chang E; Department of Radiation Oncology, Keck School of Medicine of USC, Los Angeles, CA 90033, USA., Amin AG; Department of Neurological Surgery, University of Washington, Seattle, WA 98115, USA., Foote M; Department of Radiation Oncology, Princess Alexandra Hospital, University of Queensland, and ICON Cancer Centre, Brisbane, Queensland, Australia., Gibbs I; Department of Radiation Oncology, Stanford University, Stanford, California., Kim M; Department of Radiation Oncology, University of Washington, Seattle, WA, USA., Palmer J; Department of Radiation Oncology, Arthur G. James Cancer Hospital/The Ohio State University, Columbus, OH, USA., Lo S; Department of Radiation Oncology, University of Washington, Seattle, WA, USA., Redmond KJ; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA. Electronic address: kjanson3@jhmi.edu.
Jazyk:	angličtina
Zdroj:	Practical radiation oncology [Pract Radiat Oncol] 2024 Sep 02. Date of Electronic Publication: 2024 Sep 02.
DOI:	10.1016/j.prro.2024.08.004
Abstrakt:	Purpose: Spinal stereotactic body radiation therapy (SBRT) has become the standard of care in management of patients with limited sites of metastatic disease, radio-resistant histologies, painful vertebral metastases with long life expectancy and cases of reirradiation. Our case-based guidelines aim to assist radiation oncologists in the appropriate utilization of SBRT for common, yet challenging, cases of spinal metastases. Materials and Methods: Cases were selected to include scenarios of large volume sacral disease with nerve entrapment, medically inoperable disease abutting the thecal sac, and local failure after prior SBRT. Relevant literature was reviewed, and areas requiring further investigation were discussed to offer a framework for evidence-based clinical practice. Results: Spinal SBRT can be effectively delivered in challenging cases following multidisciplinary discussion by utilizing a methodical approach to patient selection, appropriate dose selection, and adherence to evidence-based dose constraints. Conclusions: The Radiosurgery Society's case-based practice review offers guidance to practicing physicians treating technically challenging SBRT candidate patients with spinal metastases. Competing Interests: Declaration of competing intererst Anubhav Amin reports receiving consulting fees and payment for lectures from Globus. Samuel Chao reports payment for travel, honoraria and research support from Blue Earth Diagnostics and honoraria from GE Healthcare and Varian Medical Systems. Matthew Foote reports research grant from Elekta; consulting fees and honoraria from Varian and Elekta and leadership role with stereotactic interest group of Australasia. Matthias Guckenberger reports grants from Viewray, Siemens Healthineers and Astra Zeneca; consulting fees and honoraria from Astra Zeneca; leadership role with ESTRO. Daniel Koffler reports internal departmental support for attending meetings; patent for Chiemric Immunomagnetic nanosensors for cancer stem cell imaging and leadership role in ESTRO workshop group in spatially fractionated radiation therapy. Simon S. Lo reports grant funding from Kuni Foundation, Hutchinson Center, and Elekta; he has travel support from the Japanese Society for Radiation Oncology (JASTRO); and he serves as member of the Board of Directors and National Medical Director of the Distinction in Practice in Stereotatic Radiotherapy Program for the Radiosurgery Society and Alternate Councilor for the American College of Radiology. Kristin J. Redmond reported receiving research support from Accuray; participating on a data and safety monitoring board for BioMimetix, travel expenses and grant funding from Icotec; research funding from Canon and patent pending with Canon, and receiving travel expenses from Brainlab. Daniel Lubelski reports consulting fees from Carbofix, Mindset Medical and Dillon Technologies. Arjun Sahgal has received research grants from Elekta AB, Varian, Seagen, and Brainlab; is an advisor/consultant with Varian, Elekta (Gamma Knife Icon), Brainlab; has received honoraria for past educational seminars from AstraZeneca, Elekta, Varian, Brainlab, Cerapedics, and Seagen, Carbo FIX; is a vice president of the International Stereotactic Radiosurgery Society, is a cochair of the AO Spine Knowledge Forum Tumor, belongs to the Elekta MR-Linac Research Consortium and is a Clinical Steering Committee member, and chairs the Elekta Oligometastases Group and the Elekta Gamma Knife Icon Group. Sankar Siva received salary support from Cancer Council Victoria via the Colebatch Fellowship; grants or contracts from Varian, Bayer Pharmaceuticals, Merck Sharp & Dohme; payment or honoraria for lectures, presentations, speaker's bureaus, manuscript writing, or educational events from AstraZeneca, Varian, and Roche Pharmaceuticals and Telix pharmaceuticals; a leadership or fiduciary role on the American Society of Radiation Oncology Science Council and the Advanced Radiotherapy Techniques committee of the International Association for the Study of Lung Cancer; and is on the board of directors of the Radiosurgery Society, within the past 36 months. Balamurugan Vellayappan reports honoraria from Elekta and support for travel from Brainlab. (Copyright © 2024. Published by Elsevier Inc.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu